Ticker Launch

SPAC · Merger completed

Locust Walk Acquisition Corp.

Business combination with eFFECTOR Therapeutics, Inc.

Locust Walk Acquisition Corp. is a blank-check company (SPAC) that raised $153M in its initial public offering on Jan 11, 2021, listing on Nasdaq. It completed its business combination with eFFECTOR Therapeutics, Inc. on Aug 25, 2021; the combined company is eFFECTOR Therapeutics, Inc. (EFTR). Cantor led the IPO. Ellenoff Grossman & Schole advised the underwriters on the IPO.

Status
Merger completed
IPO date
Jan 11, 2021
IPO size
$153M
IPO exchange
Nasdaq
Target
eFFECTOR Therapeutics, Inc.
Announced
May 27, 2021
Closed
Aug 25, 2021
Combined company
eFFECTOR Therapeutics, Inc. (EFTR)
IPO underwriters
Cantor
Underwriters' counsel (IPO)
Ellenoff Grossman & Schole

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021